Janssen to access ChemDiv discovery chemistry platform

By Melissa Fassbender contact

- Last updated on GMT

Janssen to access ChemDiv discovery chemistry platform

Related tags: Pharmacology, Collaboration, Chemistry

ChemDiv is providing Janssen Research & Development with access to its small molecule discovery platform resources as part of a hit identification collaboration.

According to ChemDiv, the collaboration will focus on identifying potent hit series for a range of targets across multiple therapeutic areas. Per the agreement, Janssen will receive open-ended access to ChemDiv's discovery chemistry platform.

Ron Demuth, General Manager of ChemDiv, told us, “The goals are to expand Janssen's access to novel and unique discovery chemistry while reducing their upfront costs of accessing these resources.​”

Demuth explained the companies have worked collaboratively for several years in multiple business models, including pipeline enrichment via multiple jointly-conducted integrated discovery projects aimed at validating and drugging targets for specific disease indications, compound inventory enrichment deals, medicinal chemistry projects, as well as preclinical and clinical development of Janssen candidates.

As part of the most recent collaboration, ChemDiv will receive upfront access fees, and milestones based on successful new leads and candidates developed from these resources.

The CRO is engaged with four other Pharma partners in similar business models, the first of which was initiated in 2010.

Demuth said the collaborations have been “quite productive in the sense that many new leads development candidates have resulted​.”

(Feature image: iStock/fotohunter)

Related topics: Preclinical Research, Preclinical

Related news

Show more

Related products

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars